Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
18.31
-0.01 (-0.03%)
Nov 5, 2024, 1:15 PM EST - Market open
CRBP Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | - | - | - | 0.88 | 3.94 | 36.14 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | -77.61% | -89.11% | 649.51% | Upgrade
|
| Cost of Revenue | 26.16 | 31.17 | 16.14 | 36.45 | 98.27 | 89.6 | Upgrade
|
| Gross Profit | -26.16 | -31.17 | -16.14 | -35.56 | -94.33 | -53.46 | Upgrade
|
| Selling, General & Admin | 14.04 | 13.91 | 18.7 | 20.43 | 28.48 | 23.64 | Upgrade
|
| Operating Expenses | 14.04 | 13.91 | 18.7 | 20.43 | 28.48 | 23.64 | Upgrade
|
| Operating Income | -40.2 | -45.08 | -34.84 | -55.99 | -122.81 | -77.1 | Upgrade
|
| Interest Expense | -3.35 | -3.81 | -3.1 | -2.71 | -1.13 | - | Upgrade
|
| Interest & Investment Income | 1.96 | 0.89 | 0.96 | 0.88 | 0.1 | 1.23 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.01 | 0.01 | -0.43 | -0.38 | -0.45 | -0.16 | Upgrade
|
| Other Non Operating Income (Expenses) | 6.62 | 3.39 | 0.05 | 12.56 | 13.02 | 4.58 | Upgrade
|
| EBT Excluding Unusual Items | -34.97 | -44.6 | -37.35 | -45.64 | -111.27 | -71.45 | Upgrade
|
| Legal Settlements | - | - | -5 | - | - | - | Upgrade
|
| Pretax Income | -34.97 | -44.6 | -42.35 | -45.64 | -111.27 | -71.45 | Upgrade
|
| Net Income | -34.97 | -44.6 | -42.35 | -45.64 | -111.27 | -71.45 | Upgrade
|
| Net Income to Common | -34.97 | -44.6 | -42.35 | -45.64 | -111.27 | -71.45 | Upgrade
|
| Shares Outstanding (Basic) | 7 | 4 | 4 | 4 | 3 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 4 | 4 | 4 | 3 | 2 | Upgrade
|
| Shares Change (YoY) | 67.92% | 3.76% | 1.85% | 57.23% | 22.28% | 12.10% | Upgrade
|
| EPS (Basic) | -4.96 | -10.31 | -10.15 | -11.15 | -42.72 | -33.55 | Upgrade
|
| EPS (Diluted) | -4.96 | -10.31 | -10.15 | -11.15 | -42.72 | -33.55 | Upgrade
|
| Free Cash Flow | -30.09 | -36.1 | -37.56 | -48.24 | -100.17 | -48.46 | Upgrade
|
| Free Cash Flow Per Share | -4.27 | -8.34 | -9.01 | -11.78 | -38.46 | -22.75 | Upgrade
|
| Gross Margin | - | - | - | - | - | -147.91% | Upgrade
|
| Operating Margin | - | - | - | -6350.09% | -3119.20% | -213.33% | Upgrade
|
| Profit Margin | - | - | - | -5176.38% | -2826.08% | -197.69% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -5470.98% | -2544.18% | -134.09% | Upgrade
|
| EBITDA | -39.6 | -44.44 | -34.07 | -54.99 | -121.69 | -76.37 | Upgrade
|
| EBITDA Margin | - | - | - | - | - | -211.28% | Upgrade
|
| D&A For EBITDA | 0.6 | 0.64 | 0.76 | 1 | 1.12 | 0.74 | Upgrade
|
| EBIT | -40.2 | -45.08 | -34.84 | -55.99 | -122.81 | -77.1 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -213.33% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.